We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 117

End of German Olanzapine battle: Federal Supreme Court upholds patent
  • Bird & Bird
  • Germany
  • March 11 2009

On December 16, 2008 the Federal Supreme Court gave its judgment determining the validity of the Olanzapine patent, this was further to its revocation by the Federal Patent Court at first instance


UK Patents Court judgment in Laboratorios Almirall SA v Boehringer Ingelheim International GmbH
  • Bird & Bird
  • United Kingdom
  • March 11 2009

This case concerned a tit-for-tat revocation of two patents claiming the combinations of a particular anticholinergic with -agonists for treating respiratory illnesses


Edwards Lifesciences AG v Cook Biotech Incorporated
  • Bird & Bird
  • United Kingdom
  • July 17 2009

Mr Justice Kitchin handed down a decision only four weeks after the hearing, finding Cook’s patent invalid and not infringed by Edwards’ SAPIEN heart valve


New legislation on falsified medicines in the European Union
  • Bird & Bird
  • European Union
  • May 3 2011

The European Parliament has adopted Directive 201084EU (the 'Directive') aimed at preventing the entry of medicinal products which falsely indicate their identity, history or source into the legal supply chain


Patents Court judgment in Ratiopharm GmbH and Sandoz Limited v Napp Pharmaceutical Holdings Limited
  • Bird & Bird
  • United Kingdom
  • March 11 2009

The Patents Court (Mr Justice Floyd) handed judgment down on 16 December 2008 relating to two patents regarding formulations to achieve slow release of the opioid pain killing drug, oxycodone


Status of the insufficiencyobviousness squeeze - an appraisal of the House of Lords’ Generics et al v Lundbeck judgments
  • Bird & Bird
  • United Kingdom
  • May 1 2009

In February 2009 the House of Lords unanimously dismissed an appeal by a number of pharmaceutical companies against the Court of Appeal’s decision to not revoke Lundbeck’s escitalopram patent on grounds of insufficiency


Preliminary injunctions in pharmaceutical patent actions
  • Bird & Bird
  • Italy
  • May 13 2009

By a decision of 15 April 2009 issued in a preliminary injunction proceeding, the Court of Milan held that the mere grant of a Marketing Authorisation (MA) for a generic pharmaceutical product does not constitute an imminent threat of patent infringement


Patent decisions on patents for chiral compounds
  • Bird & Bird
  • United Kingdom
  • May 13 2009

A chiral compound is one which has at least one asymmetric carbon centre


ECJ decision in AHP Manufacturing BV v the Bureau voor de Industriele Eigendom (Case C-48207)
  • Bird & Bird
  • European Union
  • October 13 2009

The ECJ has accepted that the holder of a basic patent is entitled to one SPC regardless of whether other SPCs have already been granted to other holders of one or more other basic patents


High Court’s rejection of du Pont’s UK paediatric SPC extension for Cozaar overturned by the Court of Appeal
  • Bird & Bird
  • United Kingdom
  • October 13 2009

In E I du Pont Nemours & Co.’s SPC Application (2009 EWHC 1112 (Ch)) the High Court considered an appeal from a decision of the UK Intellectual Property Office to refuse a six month extension of a Supplementary Protection Certificate covering Cozaar (Losartan, an antihypertensive) under the Paediatric Regulation 19012006